FLXN Stock Performance, Insider Transaction and News

FLXN - Flexion Therapeutics, Inc.

Market Cap	458.93M	P/E	-	EPS this Y	49.00%	Ern Qtrly Grth	-
Income	-100.72M	Forward P/E	14.71	EPS next Y	148.10%	50D Avg Chg	14.00%
Sales	100.4M	PEG	-0.35	EPS past 5Y	-	200D Avg Chg	10.00%
Dividend	N/A	Price/Book	N/A	EPS next 5Y	20.00%	52W High Chg	-33.00%
Recommedations	1.00	Quick Ratio	3.90	Shares Outstanding	50.32M	52W Low Chg	112.00%
Insider Own	3.09%	ROA	-20.20%	Shares Float	45.63M	Beta	1.53
Inst Own	70.05%	ROE	-	Shares Shorted/Prior	2.16M/3.51M	Price	9.12
Gross Margin	79.17%	Profit Margin	-100.32%	Avg. Volume	2,157,560	Target Price	27.00
Oper. Margin	-77.47%	Earnings Date	Nov 12	Volume		Change	0.00%

Healthcare | Drug Manufacturers | United States

About Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. As of November 19, 2021, Flexion Therapeutics, Inc. operates as a subsidiary of Pacira BioSciences, Inc..

FLXN Chatroom

UltraInstinct Posted - 06/28/24

$FLXN was the first stock I ever bought back in 2015 and looks like nothing changed in 9 years. Its at the same fucking price 😓

ModernWorldNews Posted - 1 year ago

$FLXN modernworldnews.com - Flexion Therapeutics is a biopharmaceutical company focused on developing innovative solutions for musculoskeletal disorders. Why did the skeleton refuse to go to the party? He had nobody to dance with! Flexion Therapeutics could have a bone-rattling good run in the future.

MoonShot77 Posted - 1 year ago

$CYDY Held a couple biotechs into FDA catalysts. Both $PTLA and $FLXN went down in the days prior to a positive FDA outcome. On the flipside also been in a few that ramped into Fda catalysts only to see a negative outcome. This is nothing but a buying opportunity, I expect a great conference call. King Cyrus the Great is about to free us from the evils of FDA Babylon. Extremely

risenhoover Posted - 03/26/23

$FLXN FLXN / Flexion Therapeutics Inc Price Target Updated https://fintel.io/sfo/us/flxn?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/25/23

$FLXN FLXN / Flexion Therapeutics Inc Price Target Updated https://fintel.io/sfo/us/flxn?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/24/23

$FLXN FLXN / Flexion Therapeutics Inc Price Target Updated https://fintel.io/sfo/us/flxn?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

risenhoover Posted - 03/23/23

$FLXN FLXN / Flexion Therapeutics Inc Price Target Updated https://fintel.io/sfo/us/flxn?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget